Cdc25A Regulates Matrix Metalloprotease 1 through Foxo1 and Mediates Metastasis of Breast Cancer Cells
暂无分享,去创建一个
R. Ganju | T. Prior | Zhaojia Wu | Rulong Z. Shen | Thomas W. Prior | Rulong Shen | X. Zou | Ramesh K. Ganju | Xiaoling Feng | Zhaojia Wu | Yongsheng Wu | William Hankey | Lei Li | Xianghong Zou | Xiaoling Feng | W. Hankey | Yongsheng Wu | Lei Li
[1] P. Dhawan,et al. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. , 2002, The Journal of biological chemistry.
[2] H. Piwnica-Worms,et al. Absence of Apparent Phenotype in Mice Lacking Cdc25C Protein Phosphatase , 2001, Molecular and Cellular Biology.
[3] H. Kiyokawa,et al. The Cell Cycle-Regulatory CDC25A Phosphatase Inhibits Apoptosis Signal-Regulating Kinase 1 , 2001, Molecular and Cellular Biology.
[4] Zhiwei Wang,et al. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model , 2006, Molecular Cancer Therapeutics.
[5] D. Nimbalkar,et al. Transforming Growth Factor β Facilitates β-TrCP-Mediated Degradation of Cdc25A in a Smad3-Dependent Manner , 2005, Molecular and Cellular Biology.
[6] Michele Pagano,et al. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. , 2003, Nature.
[7] 郑俊. Maintenance , 2002, The Islamic Law of Personal Status.
[8] J. Ludlow,et al. Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. , 1996, Cancer research.
[9] L. Tessarollo,et al. Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation , 2002, Nature Genetics.
[10] D. Tindall,et al. Dynamic FoxO transcription factors , 2007, Journal of Cell Science.
[11] A. Fukamizu,et al. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. , 2008, Molecular cell.
[12] R. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.
[13] W. Gerald,et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.
[14] I. Poola,et al. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis , 2005, Nature Medicine.
[15] E. Schleicher,et al. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. , 2008, Carcinogenesis.
[16] Ajit Varki,et al. Molecular basis of metastasis. , 2009, The New England journal of medicine.
[17] M. Tada,et al. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma. , 2008, The Journal of surgical research.
[18] A. Miyauchi,et al. Expression of cdc25A and cdc25B phosphatase in breast carcinoma , 2004, Breast cancer.
[19] P. Dhawan,et al. Correction: A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma Cells , 2001, The Journal of Biological Chemistry.
[20] S. Zucker,et al. Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer* , 2008, Journal of Biological Chemistry.
[21] D. Beach,et al. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins , 1991, Cell.
[22] H. Piwnica-Worms,et al. Normal Cell Cycle and Checkpoint Responses in Mice and Cells Lacking Cdc25B and Cdc25C Protein Phosphatases , 2005, Molecular and Cellular Biology.
[23] M. Loda,et al. CDC25 phosphatases as potential human oncogenes. , 1995, Science.
[24] Florian Kronenberg,et al. Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[25] Esther B. E. Becker,et al. Activation of FOXO1 by Cdk1 in Cycling Cells and Postmitotic Neurons , 2008, Science.
[26] B. Burgering,et al. Stressing the role of FoxO proteins in lifespan and disease , 2007, Nature Reviews Molecular Cell Biology.
[27] I. Fidler,et al. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. , 2007, Endocrine reviews.
[28] B. Gogebakan,et al. CDC25A gene 263C/T, -350C/T, and -51C/G polymorphisms in breast carcinoma , 2010, Tumor Biology.
[29] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[30] Jean-Marc Guinebretière,et al. A six-gene signature predicting breast cancer lung metastasis. , 2008, Cancer research.
[31] M. Loda,et al. Role of the Cdc25A phosphatase in human breast cancer. , 2000, The Journal of clinical investigation.
[32] Christian R. Dolder,et al. A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer , 2007, Therapeutics and clinical risk management.
[33] Q. Cai,et al. Aberrant Polo-Like Kinase 1-Cdc25A Pathway in Metastatic Hepatocellular Carcinoma , 2008, Clinical Cancer Research.
[34] H Nojima,et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. , 1994, The EMBO journal.
[35] G. Hortobagyi,et al. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] D. Nimbalkar,et al. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. , 2005, Molecular and cellular biology.
[37] E. El-Omar,et al. The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers , 2009, Histopathology.
[38] A. Agarwal,et al. Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. , 2009, Cancer research.
[39] R. Flavell,et al. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. , 2009, Immunity.
[40] V. Trivedi,et al. Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site , 2009, Cell.
[41] A. Gudkov,et al. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. , 2002, Genes & development.
[42] J. Massagué,et al. Molecular basis of metastasis. , 2008, The New England journal of medicine.
[43] L. Mao,et al. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. , 1998, Cancer research.
[44] K. Arden. FoxOs in Tumor Suppression and Stem Cell Maintenance , 2007, Cell.
[45] J. Rudolph. Inhibiting transient protein–protein interactions: lessons from the Cdc25 protein tyrosine phosphatases , 2007, Nature Reviews Cancer.
[46] Michele Pagano,et al. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage , 2003, Nature.
[47] Hui Zhao,et al. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] H. Piwnica-Worms,et al. Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding , 2003, Molecular and Cellular Biology.
[49] John Quackenbush,et al. Confounding effects in "A six-gene signature predicting breast cancer lung metastasis". , 2009, Cancer research.
[50] S. Barsky,et al. A Novel Mechanism of Indole-3-Carbinol Effects on Breast Carcinogenesis Involves Induction of Cdc25A Degradation , 2010, Cancer Prevention Research.
[51] D. Tindall,et al. CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA Damage , 2006, Science.
[52] M. J. Abedin,et al. Autophagy delays apoptotic death in breast cancer cells following DNA damage , 2007, Cell Death and Differentiation.
[53] D. Nimbalkar,et al. Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice. , 2007, Cancer research.
[54] D. Kennedy,et al. A Comparative Review of Thermography as a Breast Cancer Screening Technique , 2009, Integrative cancer therapies.
[55] Zhiyong Guo,et al. Available Online , 1600 .
[56] J. Cleveland,et al. Essential Role of Phospholipase Cγ2 in Early B-Cell Development and Myc-Mediated Lymphomagenesis , 2006, Molecular and Cellular Biology.
[57] E. Appella,et al. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. , 2008, Cancer cell.
[58] R. Maestro,et al. Overexpression of CDC25A and CDC25B in head and neck cancers. , 1997, Cancer research.
[59] D. Christiani,et al. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. , 2009, Carcinogenesis.
[60] I. Hoffmann,et al. Cell cycle regulation by the Cdc25 phosphatase family. , 2000, Progress in cell cycle research.
[61] Bernard Ducommun,et al. CDC25 phosphatases in cancer cells: key players? Good targets? , 2007, Nature Reviews Cancer.
[62] I. Hoffmann,et al. Ectopic Expression of Cdc25A Accelerates the G1/S Transition and Leads to Premature Activation of Cyclin E- and Cyclin A-Dependent Kinases , 1999, Molecular and Cellular Biology.